CVR: 33062214
Previous names: CONCIT PHARMA ApS, CONTERA PHARMA ApS
CONTERA PHARMA A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named CONTERA PHARMA ApS and CONCIT PHARMA ApS. The management consists of Thomas Nikolaj Sager. The company is owned by Bukwang Pharmaceutical Co., Ltd. The company has 1 employee. In 2025, the company reported a gross profit of DKK 20,632,306 and a net result of DKK -4,783,781 compared with DKK -69,213,744 the year before. Equity amounted to DKK 79,471,802.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at udvikle nye lægemidler og dermed beslægtet virksomhed.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 20.6 mio. | -4.8 mio. | 97.6 mio. | 79.5 mio. | 14 | |
| 2024 | -54.1 mio. | -69.2 mio. | 63.6 mio. | 54.4 mio. | 19 | |
| 2023 | -59 mio. | -71.3 mio. | 92.4 mio. | 86.3 mio. | 17 | |
| 2022 | -44.8 mio. | -56.9 mio. | 115.7 mio. | 106.6 mio. | 14 | |
| 2021 | -24.2 mio. | -31.5 mio. | 167.2 mio. | 163.4 mio. | 13 | |
| 2020 | -9.7 mio. | -12.3 mio. | 201.3 mio. | 195 mio. | 4 | |
| 2019 | -1.2 mio. | -2 mio. | 18.2 mio. | 17.8 mio. | 1 | |
| 2018 | 1.5 mio. | -968 t. | 3.6 mio. | 3.2 mio. | 2 | |
| 2017 | 1.4 mio. | -419 t. | 1.4 mio. | 1 mio. | 2 | |
| 2016 | 3.1 mio. | 866 t. | 1.6 mio. | 1.5 mio. | - | |
| 2015 | 445 t. | -1.1 mio. | 852 t. | 601 t. | - | |
| 2014 | -126 t. | -3.2 mio. | 1.9 mio. | 1.7 mio. | - | |
| 2013 | -3.4 mio. | -4.7 mio. | 4.1 mio. | 1.7 mio. | - | |
| 2012 | -3.7 mio. | -4.2 mio. | 6.8 mio. | 6.4 mio. | - |
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreCompared to 1.053 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Contact info changed: new phone: 31186611, new email: [email protected], new website: www.conterapharma.com (April 16, 2026).
CONTERA PHARMA A/S has published its annual report for 2025. Gross profit came to DKK 20,632,306, and the net result was DKK -4,783,781.
As of April 10, 2026, Mi Chung Ahn has joined the board of directors of CONTERA PHARMA A/S.
As of April 10, 2026, Jee Hun Kim has joined the board of directors of CONTERA PHARMA A/S.
As of April 10, 2026, WooHyun Lee has left the board of directors of CONTERA PHARMA A/S.
As of April 9, 2026, Mi Chung Ahn has left the board of directors of CONTERA PHARMA A/S.
CONTERA PHARMA A/S has published its annual report for 2024. Gross profit came to DKK -54,083,946, and the net result was DKK -69,213,744.
As of April 15, 2025, Mi Chung Ahn has joined the board of directors of CONTERA PHARMA A/S.
As of April 15, 2025, Soo Yeon Park has left the board of directors of CONTERA PHARMA A/S.
As of December 1, 2024, Mahmoud Mahmoudian has joined the board of directors of CONTERA PHARMA A/S.
As of December 1, 2024, Soo Yeon Park has joined the board of directors of CONTERA PHARMA A/S.
CONTERA PHARMA A/S has published its annual report for 2023. Gross profit came to DKK -58,993,909, and the net result was DKK -71,320,299.
As of April 1, 2024, is registered as an owner of CONTERA PHARMA A/S with an ownership share of 90%.
As of March 1, 2024, Paul Ejnar Gremaud Kristjansen has joined the board of directors of CONTERA PHARMA A/S.
As of November 17, 2023, WooHyun Lee has joined the board of directors of CONTERA PHARMA A/S.
As of November 17, 2023, Hee Won Yoo has left the board of directors of CONTERA PHARMA A/S.
As of November 16, 2023, WooHyun Lee has left the board of directors of CONTERA PHARMA A/S.
As of July 3, 2023, Jae Young Lee has joined the board of directors of CONTERA PHARMA A/S.
As of July 3, 2023, Sung Joon Kim has left the board of directors of CONTERA PHARMA A/S.
CONTERA PHARMA A/S has published its annual report for 2022. Gross profit came to DKK -44,831,824, and the net result was DKK -56,868,331.
As of February 9, 2023, Sun Ho Kim has left the board of directors of CONTERA PHARMA A/S.
As of July 1, 2022, Thomas Nikolaj Sager has joined the board of directors of CONTERA PHARMA A/S.
As of July 1, 2022, WooHyun Lee has joined the board of directors of CONTERA PHARMA A/S.
CONTERA PHARMA A/S has published its annual report for 2021. Gross profit came to DKK -24,154,462, and the net result was DKK -31,518,831.
As of March 28, 2022, Sung Joon Kim has joined the board of directors of CONTERA PHARMA A/S.
As of March 28, 2022, Eun Ju Kim has left the board of directors of CONTERA PHARMA A/S.
As of April 30, 2021, Sun Ho Kim has joined the board of directors of CONTERA PHARMA A/S.
As of April 30, 2021, Jung Yoon Um has left the board of directors of CONTERA PHARMA A/S.
CONTERA PHARMA A/S has published its annual report for 2020. Gross profit came to DKK -9,724,551, and the net result was DKK -12,258,975.
As of December 1, 2020, Thomas Nikolaj Sager is registered as adm. dir. of CONTERA PHARMA A/S.
As of December 1, 2020, John Bondo Hansen has stepped down as adm. dir. of CONTERA PHARMA A/S.
As of November 13, 2020, Eun Ju Kim has joined the board of directors of CONTERA PHARMA A/S.
As of November 13, 2020, Sang Hoon Kim has left the board of directors of CONTERA PHARMA A/S.
CONTERA PHARMA A/S has published its annual report for 2019. Gross profit came to DKK -1,249,644, and the net result was DKK -2,002,844.
CONTERA PHARMA A/S has published its annual report for 2018. Gross profit came to DKK 1,519,395, and the net result was DKK -967,629.
As of February 22, 2019, Jung Yoon Um has joined the board of directors of CONTERA PHARMA A/S.
On February 22, 2019, the company changed its name from CONTERA PHARMA ApS to CONTERA PHARMA A/S.
As of June 30, 2018, Mikael Søndergaard Thomsen has stepped down as director of CONTERA PHARMA A/S.
CONTERA PHARMA A/S has published its annual report for 2017. Gross profit came to DKK 1,418,538, and the net result was DKK -418,534.
CONTERA PHARMA A/S has published its annual report for 2016. Gross profit came to DKK 3,107,817, and the net result was DKK 866,364.
CONTERA PHARMA A/S has published its annual report for 2015. Gross profit came to DKK 445,321, and the net result was DKK -1,083,182.
CONTERA PHARMA A/S has published its annual report for 2014. Gross profit came to DKK -125,656, and the net result was DKK -3,237,004.
As of November 24, 2014, Sang Hoon Kim has joined the board of directors of CONTERA PHARMA A/S.
As of November 24, 2014, Hee Won Yoo has joined the board of directors of CONTERA PHARMA A/S.
As of November 24, 2014, Bobby G Soni has left the board of directors of CONTERA PHARMA A/S.
As of November 24, 2014, Carsten Schou has left the board of directors of CONTERA PHARMA A/S.
As of November 24, 2014, Else Sissel Vorstrup has left the board of directors of CONTERA PHARMA A/S.
As of November 24, 2014, Joseph Donald deBethizy has left the board of directors of CONTERA PHARMA A/S.
As of November 24, 2014, Gunnar Magnus Severus Modee Persson has left the board of directors of CONTERA PHARMA A/S.
CONTERA PHARMA A/S has published its annual report for 2013. Gross profit came to DKK -3,423,079, and the net result was DKK -4,726,146.
As of November 19, 2013, Else Sissel Vorstrup has joined the board of directors of CONTERA PHARMA A/S.
As of November 19, 2013, Joseph Donald deBethizy has joined the board of directors of CONTERA PHARMA A/S.
As of November 19, 2013, John Bondo Hansen has left the board of directors of CONTERA PHARMA A/S.
On November 19, 2013, the company changed its name from CONCIT PHARMA ApS to CONTERA PHARMA ApS.
CONTERA PHARMA A/S has published its annual report for 2012. Gross profit came to DKK -3,689,746, and the net result was DKK -4,245,465.
As of October 2, 2012, PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab has been appointed auditor of CONTERA PHARMA A/S.
As of October 2, 2012, EY Godkendt Revisionspartnerselskab has stepped down as auditor of CONTERA PHARMA A/S.
As of April 18, 2012, Carsten Schou has joined the board of directors of CONTERA PHARMA A/S.
As of April 18, 2012, Gunnar Magnus Severus Modee Persson has joined the board of directors of CONTERA PHARMA A/S.
As of April 18, 2012, Frank Knudsen has left the board of directors of CONTERA PHARMA A/S.
As of April 18, 2012, Mikael Søndergaard Thomsen has left the board of directors of CONTERA PHARMA A/S.
As of April 26, 2011, Bobby G Soni has joined the board of directors of CONTERA PHARMA A/S.
As of January 7, 2011, Frank Knudsen has joined the board of directors of CONTERA PHARMA A/S.
As of December 22, 2010, EY Godkendt Revisionspartnerselskab has been appointed auditor of CONTERA PHARMA A/S.
As of December 22, 2010, PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab has stepped down as auditor of CONTERA PHARMA A/S.
As of August 6, 2010, John Bondo Hansen has joined the board of directors of CONTERA PHARMA A/S.
As of August 6, 2010, Mikael Søndergaard Thomsen has joined the board of directors of CONTERA PHARMA A/S.
As of August 6, 2010, John Bondo Hansen is registered as adm. dir. of CONTERA PHARMA A/S.
As of July 9, 2010, PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab has been appointed auditor of CONTERA PHARMA A/S.
As of July 9, 2010, Mikael Søndergaard Thomsen is registered as director of CONTERA PHARMA A/S.
CONTERA PHARMA A/S was founded on July 9, 2010.
Companies in the same industry and area
CVR 30514041
CVR 45284786
CVR 45284794
CVR 27408753
CVR 28512457
companydata.dk